3BEEBE K L, BLOCK T, DEBATrISTA C, et al. The effi- cacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats [ J ]. Behavioural Brain Res, 2006 , 171 ( 2 ) : 225-229.
4GROSS C, BLASEY C M, ROE R L, et al. Mifepristone treatment of olanzapine-induced weight gain in healthy men [ J ]. Adv Ther, 2009, 26 (10) :959-69.
5A two-week study of the efficacy and safety of mifepristone in the prevention of olanzapine-induced weight gain[OL/ EB ]. [ http://elinicaltrials, gov/ct2/show/NCT004554427 term = mifepristone&rank = 39 ].
6A 4-week study of mifepristone in the prevention of risperi- done-induced weight gain in healthy male volunteers [ OL/ EB]. [ http://clinicaltrials, gov/ct2/show/NCTO06980227 term = mifepristone&rank = 1 ].
7GROSS C, BLASEY C M, ROE R L, et al. Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men [ J ]. Obesity ( Silver Spring), 2010,18 ( 12 ) : 2295 - 2300.
8BELANOFF J K, ROTHSCHILD A J, CASSIDY F, et al. An open label trial of C-1073 (mifepristone) for psychotic major depression[ J]. Biol Psychiatry, 2002, 52 ( 5 ):386- 392.
9DEBATYISTA C, BELANOFF J, GLASS S, et al. Mifep- ristone versus placebo in the treatment of psychosis in patients with psychotic major depression [ J ]. Biol Psychiatry, 2006, 60(12):1343-1349.
10DEBATrISTA C. A double blind trial of C-1073 ( mifepris- tone) in the treatment of psychotic symptoms of psychotic major depression [ C ]. 44th Annual NCDEU Meeting,2004, Phoenix, AZ, USA.
